These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 7680614
1. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Mapara MY, Bargou R, Zugck C, Döhner H, Ustaoglu F, Jonker RR, Krammer PH, Dörken B. Eur J Immunol; 1993 Mar; 23(3):702-8. PubMed ID: 7680614 [Abstract] [Full Text] [Related]
2. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Li L, Krajewski S, Reed JC, Choi YS. Cell Immunol; 1997 May 25; 178(1):33-41. PubMed ID: 9184696 [Abstract] [Full Text] [Related]
3. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A. J Clin Invest; 1995 Jun 25; 95(6):2633-43. PubMed ID: 7539458 [Abstract] [Full Text] [Related]
4. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Leukemia; 1995 Jul 25; 9(7):1227-32. PubMed ID: 7543175 [Abstract] [Full Text] [Related]
5. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule. Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T. J Immunol; 1995 Jun 01; 154(11):5746-56. PubMed ID: 7538529 [Abstract] [Full Text] [Related]
6. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals. Carlsson M, Sundström C, Bengtsson M, Tötterman TH, Rosén A, Nilsson K. Eur J Immunol; 1989 May 01; 19(5):913-21. PubMed ID: 2525477 [Abstract] [Full Text] [Related]
7. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Lotem J, Sachs L. Cell Growth Differ; 1995 Jun 01; 6(6):647-53. PubMed ID: 7669718 [Abstract] [Full Text] [Related]
8. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M. J Immunol; 1997 Sep 01; 159(5):2108-15. PubMed ID: 9278296 [Abstract] [Full Text] [Related]
9. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G. J Leukoc Biol; 2002 Jul 01; 72(1):83-92. PubMed ID: 12101266 [Abstract] [Full Text] [Related]
10. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M. Eur J Immunol; 1996 Feb 01; 26(2):294-9. PubMed ID: 8617294 [Abstract] [Full Text] [Related]
11. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. J Clin Invest; 1994 Sep 01; 94(3):954-64. PubMed ID: 7521890 [Abstract] [Full Text] [Related]
12. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways. Mathas S, Rickers A, Bommert K, Dörken B, Mapara MY. Cancer Res; 2000 Dec 15; 60(24):7170-6. PubMed ID: 11156427 [Abstract] [Full Text] [Related]
14. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. Huston MM, Moore JP, Mettes HJ, Tavana G, Huston DP. J Immunol; 1996 Feb 15; 156(4):1392-401. PubMed ID: 8568239 [Abstract] [Full Text] [Related]
15. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Cancer Res; 1994 Mar 15; 54(6):1580-6. PubMed ID: 7511047 [Abstract] [Full Text] [Related]
16. Effect of bcl-2 on Fas antigen-mediated cell death. Itoh N, Tsujimoto Y, Nagata S. J Immunol; 1993 Jul 15; 151(2):621-7. PubMed ID: 7687619 [Abstract] [Full Text] [Related]
17. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM. J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113 [Abstract] [Full Text] [Related]
19. Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: potential role of the bcl-2 gene family in surface IgM-mediated apoptosis. Bargou RC, Bommert K, Weinmann P, Daniel PT, Wagener C, Mapara MY, Dörken B. Eur J Immunol; 1995 Mar 01; 25(3):770-5. PubMed ID: 7705407 [Abstract] [Full Text] [Related]
20. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. Mor F, Cohen IR. J Immunol; 1996 Jan 15; 156(2):515-22. PubMed ID: 8543801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]